11/4
08:58 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/4
08:58 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/4
05:40 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
11/4
05:40 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
10/15
10:10 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
10/15
07:19 am
bcrx
Rating for BCRX
Medium
Report
Rating for BCRX
10/15
07:19 am
bcrx
Rating for BCRX
Medium
Report
Rating for BCRX
10/15
05:58 am
bcrx
Rating for BCRX
Medium
Report
Rating for BCRX
10/15
05:58 am
bcrx
Rating for BCRX
Medium
Report
Rating for BCRX
10/1
08:46 am
bcrx
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its "in-line" rating reaffirmed by analysts at Evercore ISI. They now have a $8.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its "in-line" rating reaffirmed by analysts at Evercore ISI. They now have a $8.00 price target on the stock.
10/1
08:46 am
bcrx
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its "in-line" rating reaffirmed by analysts at Evercore ISI. They now have a $8.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its "in-line" rating reaffirmed by analysts at Evercore ISI. They now have a $8.00 price target on the stock.
10/1
08:36 am
bcrx
BioCryst downgraded to In Line from Outperform at Evercore ISI
Low
Report
BioCryst downgraded to In Line from Outperform at Evercore ISI
10/1
08:36 am
bcrx
BioCryst downgraded to In Line from Outperform at Evercore ISI
Low
Report
BioCryst downgraded to In Line from Outperform at Evercore ISI